Home > Journals > Minerva Urology and Nephrology > Past Issues > Minerva Urology and Nephrology 2022 August;74(4) > Minerva Urology and Nephrology 2022 August;74(4):485-7

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

EDITORIAL COMMENT   Free accessfree

Minerva Urology and Nephrology 2022 August;74(4):485-7

DOI: 10.23736/S2724-6051.22.04962-X

Copyright © 2022 EDIZIONI MINERVA MEDICA

language: English

Comment on: “The impact of age on pathological insignificant prostate cancer rates in contemporary robot-assisted prostatectomy patients despite active surveillance eligibility”

Martina MAGGI 1 , Roderick van den BERGH 2, Giorgio GANDAGLIA 3, EAU-YAU Prostate Cancer Working Party

1 Department of Maternal-Infant and Urological Sciences, Umberto I Polyclinic Hospital, Sapienza University, Rome, Italy; 2 Department of Urology, St. Antonius Hospital, Utrecht, the Netherlands; 3 Unit of Urology, Division of Oncology, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy



top of page